BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
November 15, 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
October 26, 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Oct. 26, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTC PINK: BSEM), a leading regenerative medicine company focused on the development,...
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
October 10, 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Oct. 10, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC PINK: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts
September 13, 2022 07:30 ET
|
BioStem Technologies, Inc.
Standardized methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje® and Vendaje AC® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE...
BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe
September 08, 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Reports Second Quarter 2022 Operating and Financial Results
August 22, 2022 16:01 ET
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on August 22, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Aug. 22, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
BioStem Technologies to Host Second Quarter Financial Results and Corporate Update Conference Call on August 22nd
August 16, 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies® CEO to Appear on the Benzinga All Access Show on June 17,2022
June 17, 2022 09:25 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development,...
BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results
May 16, 2022 12:25 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., May 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Inc. Reports December 31, 2021 Year End Financial Results
April 01, 2022 10:00 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., April 01, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...